Uptake of biosimilars increasing in Spain

Posted 20/05/2016

Use of biosimilars in Madrid, Spain, has increased after approaches were introduced to try and improve uptake of biosimilars in the country, according to Ain...

Clinical and regulatory issues for biosimilars Biosimilars/Research | Posted 20/05/2016
Samsung Bioepis to launch infliximab biosimilar... Biosimilars/News | Posted 20/05/2016
Perceptions of the value of generics in Brazil Generics/Research | Posted 20/05/2016
Japan proving to be a favourable market for bio... Biosimilars/General | Posted 20/05/2016
Australian generics maker opens clinical trials... Generics/General | Posted 20/05/2016
Approaches to increase uptake of biosimilars in... Biosimilars/Research | Posted 13/05/2016
Benepali wins Danish tender for etanercept Biosimilars/General | Posted 13/05/2016
Perceptions of the substitution of generics Generics/Research | Posted 13/05/2016
Generics applications under review by EMA – Apr... Generics/General | Posted 13/05/2016
FDA approves first generic rosuvastatin Generics/News | Posted 13/05/2016
A strategic approach to increase uptake of bios... Biosimilars/Research | Posted 06/05/2016
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 06/05/2016
Perceptions of the safety and side effects of g... Generics/Research | Posted 06/05/2016
China introduces new quality and efficacy requi... Policies & Legislation | Posted 06/05/2016
FDA issues guidance on data integrity and GMP Guidelines | Posted 06/05/2016
FDA approves highest number of generics in 2015 Generics/General | Posted 06/05/2016
Improving uptake of biosimilars in Spain Biosimilars/Research | Posted 29/04/2016
Perceptions of the effectiveness and quality of... Generics/Research | Posted 29/04/2016
Samsung Bioepis starts phase III trial for beva... Biosimilars/News | Posted 29/04/2016
Colombia recommends compulsory licence for Glivec Policies & Legislation | Posted 29/04/2016
Biosimilars group launched in UK to improve bio... Biosimilars/General | Posted 29/04/2016
India’s bulk drug exports on the increase Generics/General | Posted 29/04/2016
US rheumatologists in favour of distinct names... Biosimilars/General | Posted 22/04/2016
Payers in US getting ready for biosimilars Reports | Posted 22/04/2016
Generics perceptions in patients, pharmacists a... Generics/Research | Posted 22/04/2016
Biosimilars: the clinical perspective Biosimilars/Research | Posted 22/04/2016
New administration route for epoetin alfa biosi... Biosimilars/News | Posted 22/04/2016
Australia announces price cuts for common presc... Policies & Legislation | Posted 22/04/2016
Sun Pharma to buy 14 drug brands from Novartis... Generics/News | Posted 22/04/2016
A multidisciplinary perspective on biosimilars Biosimilars/Research | Posted 15/04/2016
Substitution of generic antiepileptic drugs Generics/Research | Posted 15/04/2016
Biosimilars: management of clinical issues Biosimilars/Research | Posted 15/04/2016
BioOutsource launches ready-to-use biosimilarit... Biosimilars/News | Posted 15/04/2016
Apotex launches generic of nasal allergy treatment Generics/News | Posted 15/04/2016
India caps prices of 530 essential drugs Policies & Legislation | Posted 15/04/2016
FDA approves infliximab biosimilar Inflectra Biosimilars/News | Posted 08/04/2016
EMA recommends approval of infliximab biosimila... Biosimilars/News | Posted 08/04/2016
Biosimilars of insulin glargine Biosimilars/General | Posted 08/04/2016
European regulatory pathways for biosimilars Biosimilars/Research | Posted 08/04/2016


Follow-on glatiramer acetate gains European approval Posted 13/05/2016

Netherlands-based biologicals company Synthon announced on 12 April 2016 that...


FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015